Improving CAR T-cell therapy for children with leukemia

Improving CAR T-cell therapy for Pediatric B-cell Acute Lymphoblastic Leukemia (B-ALL)

NIH-funded research St. Jude Children's Research Hospital · NIH-10807843

This study is looking at a new kind of CAR T-cell therapy for kids with B-cell Acute Lymphoblastic Leukemia (B-ALL) to see if using special donor cells can make the treatment safer and more effective, while also helping the cells stay in the body longer to keep the cancer from coming back.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital NIH-funded
Lab location1 site (Memphis, United States)
Project IDNIH-10807843 on NIH RePORTER

What this research studies

This research focuses on enhancing CAR T-cell therapy specifically for pediatric patients suffering from B-cell Acute Lymphoblastic Leukemia (B-ALL). The approach involves testing a new type of CAR T-cell product that uses donor memory T-cells to reduce the risk of complications while aiming to improve treatment outcomes. The study will also explore dual-antigen targeting to help maintain remission and enhance the persistence of the CAR T-cells in the body. Patients will be closely monitored through a Phase I clinical trial to gather data on the effectiveness and safety of these innovative therapies.

Who could benefit from this research

Good fit: Ideal candidates for this research are pediatric patients under 21 years of age diagnosed with B-cell Acute Lymphoblastic Leukemia.

Not a fit: Patients with other types of leukemia or those over the age of 21 may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and safer treatment options for children with high-risk leukemia.

How similar studies have performed: Previous research has shown promise in CAR T-cell therapies for pediatric leukemia, indicating that this approach has the potential for significant advancements.

Where this research is happening

Memphis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.